Istituto Clinico Humanitas Rozzano, IRCCS

Rozzano 20089

0 studies enrolling now · 2 studies all time

What they study most

Ulcerative Colitis, Urinary Bladder Neoplasms

Studies at this site

• A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder — Running, not enrolling
• A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling